M&R Capital Management’s Elevance Health ELV Stock Holding History

M&R Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115	Closed	-$51.1K	–	623
2023 Q2	$51.1K	Hold	115	–	–	0.01%	241
2023 Q1	$52.9K	Hold	115	–	–	0.01%	233
2022 Q4	$59K	Hold	115	–	–	0.02%	217
2022 Q3	$52K	Hold	115	–	–	0.01%	216
2022 Q2	$55K	Hold	115	–	–	0.01%	216
2022 Q1	$56K	Hold	115	–	–	0.01%	229
2021 Q4	$53K	Hold	115	–	–	0.01%	231
2021 Q3	$42K	Hold	115	–	–	0.01%	242
2021 Q2	$43K	Hold	115	–	–	0.01%	248
2021 Q1	$41K	Hold	115	–	–	0.01%	237
2020 Q4	$36K	Hold	115	–	–	0.01%	260
2020 Q3	$30K	Hold	115	–	–	0.01%	278
2020 Q2	$30K	Hold	115	–	–	0.01%	280
2020 Q1	$26K	Hold	115	–	–	0.01%	287
2019 Q4	$34K	Hold	115	–	–	0.01%	295
2019 Q3	$27K	Hold	115	–	–	0.01%	330
2019 Q2	$32K	Hold	115	–	–	0.01%	316
2019 Q1	$30K	Hold	115	–	–	0.01%	325
2018 Q4	$30K	Hold	115	–	–	0.01%	313
2018 Q3	$31K	Hold	115	–	–	0.01%	336
2018 Q2	$27K	Hold	115	–	–	0.01%	341
2018 Q1	$25K	Hold	115	–	–	0.01%	359
2017 Q4	$25K	Buy	+115	New	+$24.5K	0.01%	361

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

M&R Capital Management's ELV Position: Q3 2023 in Review

M&R Capital Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 115 shares — an estimated $51.1K sold.

M&R Capital Management first reported a position in ELV in Q4 2017 and held it in 23 quarters. The position peaked at $59K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

M&R Capital Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
M&R Capital Management sold 115 Elevance Health shares in Q3 2023, an estimated $51.1K.
M&R Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 23 quarters.
M&R Capital Management's Elevance Health position peaked at $59K in Q4 2022.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on M&R Capital Management's 13F filing for Q3 2023, filed 10 Oct 2023.